BNP Paribas Financial Markets’s Maravai LifeSciences MRVI Stock Holding History

BNP Paribas Financial Markets’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.95M	Buy	792,962 +713,689	+900%	+$3.08M	﹤0.01%	2103
2026 Q1	$224K	Sell	79,273 -33,332	-30%	-$113K	﹤0.01%	4000
2025 Q4	$366K	Buy	112,605 +79,263	+238%	+$267K	﹤0.01%	3741
2025 Q3	$95.7K	Sell	33,342 -92,520	-74%	-$236K	﹤0.01%	4322
2025 Q2	$303K	Sell	125,862 -9,640	-7%	-$20.3K	﹤0.01%	3601
2025 Q1	$299K	Buy	135,502 +69,059	+104%	+$273K	﹤0.01%	3483
2024 Q4	$362K	Buy	+66,443	New	+$428K	﹤0.01%	3501
2022 Q4	–	Sell	-14,679	Closed	-$375K	–	4389
2022 Q3	$375K	Buy	+14,679	New	+$368K	﹤0.01%	3171

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

OAM

Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BNP Paribas Financial Markets's MRVI Position: Q2 2026 in Review

BNP Paribas Financial Markets increased its Maravai LifeSciences (MRVI) stake by 900% in Q2 2026, buying an estimated $3.08M and bringing the position to 792,962 shares worth $4.95M. The position accounts for ﹤0.01% of the portfolio, ranked #2103.

BNP Paribas Financial Markets first reported a position in MRVI in Q3 2022 and has held it in 8 quarters since. 162 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

BNP Paribas Financial Markets held 792,962 shares of Maravai LifeSciences worth $4.95M as of Q2 2026.
BNP Paribas Financial Markets bought 713,689 Maravai LifeSciences shares in Q2 2026, an estimated $3.08M.
Maravai LifeSciences made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #2103 holding.
BNP Paribas Financial Markets first reported a position in Maravai LifeSciences in Q3 2022 and has held it in 8 quarters since.
162 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.